Severe relapse in a multiple sclerosis patient associated with ipilimumab treatment of melanoma

Abstract

View all access options for this article.

Weber

O’Day

Urba

. Phase I/II study of ipilimumab for patients with metastatic melanoma. J Clin Oncol 2008; 26: 5950–5956.

Hodi

O’Day

McDermott

. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 2010; 363: 711–723. [Erratum, N Engl J Med 2010; 363: 1290.]

Bot

Blank

Boogerd

. Neurological immune-related adverse events of ipilimumab.Pract Neurol 2013; 13: 278–280.

Liao

Shroff

Kamiya-Matsuoka

. Atypical neurological complications of ipilimumab therapy in patients with metastatic melanoma. Neuro Oncol 2014; 16: 589–593.